Integrative analysis of rare variants and pathway information shows convergent results between immune pathways, drug targets and epilepsy genes

Publication
bioRxiv
Nathan Skene
Nathan Skene
Lecturer and UKDRI Group Leader

My research interests include human genetics, single cell -omics and neurobiology.